Nippon Shikizai, Inc. (TYO:4920)
Japan
· Delayed Price · Currency is JPY 1,064.00
+13.00 (1.24%)
Mar 10, 2026, 3:30 PM JST
Nippon Shikizai Revenue
Nippon Shikizai had revenue of 3.51B JPY in the quarter ending November 30, 2025, a decrease of -8.66%. This brings the company's revenue in the last twelve months to 15.83B, down -8.77% year-over-year. In the fiscal year ending February 28, 2025, Nippon Shikizai had annual revenue of 17.63B with 17.16% growth.
Revenue (ttm)
15.83B
Revenue Growth
-8.77%
P/S Ratio
0.14
Revenue / Employee
32.56M
Employees
486
Market Cap
2.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 17.63B | 2.58B | 17.16% |
| Feb 29, 2024 | 15.05B | 3.29B | 27.98% |
| Feb 28, 2023 | 11.76B | 3.06B | 35.14% |
| Feb 28, 2022 | 8.70B | -441.00M | -4.82% |
| Feb 28, 2021 | 9.14B | -3.06B | -25.10% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ivy Cosmetics | 5.62B |
| Petgo | 7.69B |
| Asahi Eito Holdings | 4.34B |
| Axas Holdings | 12.45B |
| C'BON COSMETICS | 9.22B |
| Premier Anti-Aging | 15.57B |
| Adjuvant Holdings | 3.97B |
| HABA Laboratories,Inc. | 12.17B |